Picture of Oculis Holding AG logo

OCS — Oculis Holding AG News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Oculis Holding Shows Positive Phase 3, Stage 1 Diamond Trial Results Of Ocs-01 In Diabetic Macular Edema

Oct 10 (Reuters) - Oculis Holding AG  CR5.F :
    * POSITIVE PHASE 3 STAGE 1 DIAMOND TRIAL RESULTS OF OCS-01
IN
DIABETIC MACULAR EDEMA PRESENTED AT 23RD EURETINA CONGRESS
    * OCULIS HOLDING AG: PHASE 3 DIAMOND TRIAL MET PRIMARY AND
SECONDARY ENDPOINTS WITH ROBUST STATISTICAL SIGNIFICANCE
    * OCULIS HOLDING AG: ON TRACK TO COMMENCE STAGE 2 OF DIAMOND
PROGRAM WITH TWO PARALLEL GLOBAL PHASE 3 TRIALS

Source text for Eikon:  ID:nGNX62QTfX 
Further company coverage:  CR5.F 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Oculis Holding AG

See all news